Term
|
Definition
- -KeC (the elimination rate)
-the rate of elimination is proportional to the concentration of the drug
-1st order kinetics
|
|
|
Term
Time course of drug concentration |
|
Definition
-C(t)=C0-ket
C0= concentration at time 0 |
|
|
Term
|
Definition
|
|
Term
|
Definition
-Relates the concentration of drug in the compartment(plasma) to the amount introduced
-Vd=dose/C0
-if you know the Vdthen you can predict what the concentration change of the drug in the plasma will be after a bolus injection of the drug
-normalized to body weight l/kg
**not an actual volume, it is the volume needed to account for all drug introduced into the system at a given plasma concentration
|
|
|
Term
|
Definition
-relates the rate of elimination to plasma concentration
Elimination rate=CL*C
unitls of ml/min/kg
CL-->amount per drug per unit time
Ke-->change in concentration per unit time (mg/ml)/hour
|
|
|
Term
Clearance related to half life |
|
Definition
|
|
Term
Non-instaneous Delivery
official definition of Vd |
|
Definition
-We can still get the elimination rate constant from the late decay phase, but we can't extrapoalate to t=0 to get C0 and thus Vd
-so we use the official definition of Vd
-Vd=dose/(keAUC)
|
|
|
Term
|
Definition
-The delivery rate must equal the elimination rate
-Dosing rate-CL*Css
-generally takes 4-5 half lives to reach steady state
|
|
|
Term
|
Definition
-plasma-liver-kidney
-if drug is added instantaneously to central compartment, it will take some time before it is evenly distrubuted throughout the body
-this is the distribution phase and the drug concentration will fall more rapidly than during the later elimination phase
|
|
|
Term
|
Definition
-each bolus of drug raises the plasma concentration (ΔC) by
-ΔC=dose/Vd |
|
|
Term
|
Definition
-convert drug to more polar metabolite (thus increasing its water solubility
-add a polar functional group (-OH, -NH2. -SH
-always change the pharmacologic activity of the drug
|
|
|
Term
|
Definition
-polar substances or polar functional groups acquired during phase I are conjugated to endogenous polar substrates such as glucuronic acid, sulfuric acid, acetic acid, or glycine
-almost all conjugated products are completely inactive
|
|
|